His primary areas of study are Epitope, Antigen, T cell, Major histocompatibility complex and CTL*. The various areas that Scott Southwood examines in his Epitope study include Cytotoxic T cell, Peptide sequence and Virology. His work carried out in the field of Peptide sequence brings together such families of science as Peptide binding and Peptide.
His T cell research integrates issues from Molecular biology and Peripheral blood mononuclear cell. Scott Southwood has included themes like Arginine, Citrulline and HLA-DRB1 in his Major histocompatibility complex study. While the research belongs to areas of CTL*, Scott Southwood spends his time largely on the problem of Melanoma, intersecting his research to questions surrounding Adoptive cell transfer.
Scott Southwood mostly deals with Epitope, Major histocompatibility complex, Molecular biology, Human leukocyte antigen and Virology. His Epitope research integrates issues from Cytotoxic T cell, CTL* and T cell. His Major histocompatibility complex study incorporates themes from Antigen presentation and Immunogenicity.
His studies deal with areas such as In vitro, MHC restriction, T-cell receptor, MHC class II and Gene as well as Molecular biology. His biological study spans a wide range of topics, including ELISPOT, HLA-A2 Antigen and Degeneracy. His Virology research includes elements of Circumsporozoite protein and Immunodominance.
His main research concerns Human leukocyte antigen, Major histocompatibility complex, Epitope, Virology and Genetics. The various areas that Scott Southwood examines in his Human leukocyte antigen study include ELISPOT, Peripheral blood mononuclear cell and Genotype. His Major histocompatibility complex research incorporates themes from Molecular biology and Peptide.
His Epitope research is multidisciplinary, incorporating perspectives in T cell and Immunogenicity. His work carried out in the field of Virology brings together such families of science as Cellular immunity, Vaccinia and CTL*. In his research on the topic of Immunology, Hepatitis C virus, NS3, NS5A and Hepacivirus is strongly related with Cytotoxic T cell.
Scott Southwood mainly focuses on Human leukocyte antigen, Epitope, Major histocompatibility complex, Immunology and Virology. Genetics covers Scott Southwood research in Human leukocyte antigen. His Major histocompatibility complex research is included under the broader classification of Immune system.
He does research in Immunology, focusing on Immunogenicity specifically. His Virology research is multidisciplinary, relying on both Vaccinia, CTL* and Antigen. His Antigen study combines topics in areas such as Peripheral blood mononuclear cell, Viral load and Modified vaccinia Ankara.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
A. Sette;A. Vitiello;B. Reherman;P. Fowler.
Journal of Immunology (1994)
Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule.
Jonathan A. Hill;Scott Southwood;Alessandro Sette;Anthony M. Jevnikar.
Journal of Immunology (2003)
Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues.
Maria R. Parkhurst;Michael L. Salgaller;Scott Southwood;Paul F. Robbins.
Journal of Immunology (1996)
Several Common HLA-DR Types Share Largely Overlapping Peptide Binding Repertoires
Southwood S;Sidney J;Kondo A;del Guercio Mf.
Journal of Immunology (1998)
Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.
Y. Kawakami;S. Eliyahu;C. Jennings;K. Sakaguchi.
Journal of Immunology (1995)
Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides
Jeff Alexander;John Sidney;Scott Southwood;Jörg Ruppert.
Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.
H M Diepolder;J T Gerlach;R Zachoval;R M Hoffmann.
Journal of Virology (1997)
Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
Licia Rivoltini;Yutaka Kawakami;Kazuyasu Sakaguchi;Scott Southwood.
Journal of Immunology (1995)
Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.
Kyong-Mi Chang;Barbara Rehermann;John G. McHutchison;Claudio Pasquinelli.
Journal of Clinical Investigation (1997)
Melanoma-specific CD4 + T Cells Recognize Nonmutated HLA-DR-restricted Tyrosinase Epitopes
Suzanne L. Topalian;Monica I. Gonzales;Maria Parkhurst;Yong F. Li.
Journal of Experimental Medicine (1996)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: